Dippel D W, Du Ry van Beest Holle M, van Kooten F, Koudstaal P J
Department of Neurology, University Hospital Rotterdam, The Netherlands.
Neuroradiology. 2000 Sep;42(9):629-33. doi: 10.1007/s002340000369.
It has been suggested that subtle signs of early cerebral infarction on CT are important indicators of outcome and of the effect of thrombolytic treatment in acute ischaemic stroke. We studied these signs prospectively, in 260 patients with an anterior circulation stroke from a European-Australian randomised trial of lubeluzole in acute ischaemic stroke. Interobserver reliability was assessed by means of the chi statistic. The validity of the early signs was assessed by comparing the assessments of the first CT with another CT at 1 week after the onset of stroke, and with stroke outcome at 12 weeks. Each initial CT study was assessed by two of a group of five reviewers, who were blinded to each other's assessments and to the findings on the follow-up CT. The images were assessed twice, once without clinical information and again after disclosure of the side (left or right hemisphere) of the lesion. All reviewers were experienced clinicians with a special interest and training in vascular neurology and CT. The median time between stroke onset and the first CT was 3.2 h; 59% of the patients were imaged within 3 h and 77% within 6 h. More than half of the patients (52%) had a large middle cerebral artery territory (MCA) infarct on follow-up CT. Chance-adjusted interobserver agreement (chi) for any early infarct was 0.27 (95% confidence interval (CI): 0.15 to 0.39). Agreement (chi) on the extent of a middle cerebral artery (MCA) infarct and on the indication for treatment with recombinant tissue plasminogen activator (rt-PA) was fair: 0.37 and 0.35, respectively. Patients with early signs of an infarct of more than 1/3 of the MCA territory were more likely to have a large MCA infarct on follow-up CT (odds ratio 5.7, 95% confidence interval 2.8-11.5); the positive and negative predictive value of these signs was 81% and 57%, respectively. Chance-adjusted interobserver agreement on early, subtle signs of a large MCA territory infarct on CT by neurologists was thus no more than fair, and the accuracy of prediction of actual infarct size on the basis of these signs only moderate, under circumstances which resemble everyday clinical practice.
有人提出,CT上早期脑梗死的细微迹象是急性缺血性卒中预后及溶栓治疗效果的重要指标。我们在一项欧洲 - 澳大利亚关于鲁贝唑治疗急性缺血性卒中的随机试验中,对260例前循环卒中患者进行了前瞻性研究。通过卡方统计量评估观察者间的可靠性。通过比较首次CT评估结果与卒中发作1周后的另一张CT以及12周时的卒中预后,来评估早期迹象的有效性。每组五名审阅者中的两名对每项初始CT研究进行评估,他们彼此对对方的评估结果以及随访CT的结果不知情。图像评估两次,一次不参考临床信息,另一次在披露病变所在侧(左或右半球)后进行。所有审阅者均为对血管神经病学和CT有特殊兴趣且接受过相关培训的经验丰富的临床医生。卒中发作与首次CT之间的中位时间为3.2小时;59%的患者在3小时内进行了成像,77%在6小时内进行了成像。超过一半的患者(52%)在随访CT上有大面积大脑中动脉区域(MCA)梗死。对于任何早期梗死,经机会校正的观察者间一致性(卡方值)为0.27(95%置信区间(CI):0.15至0.39)。关于大脑中动脉(MCA)梗死范围以及重组组织型纤溶酶原激活剂(rt - PA)治疗指征的一致性(卡方值)一般:分别为0.37和0.35。MCA区域梗死超过1/3的早期迹象患者在随访CT上更有可能出现大面积MCA梗死(优势比5.7,95%置信区间2.8 - 11.5);这些迹象的阳性和阴性预测值分别为81%和57%。因此,在类似于日常临床实践的情况下,神经科医生对CT上大面积MCA区域梗死的早期细微迹象的经机会校正的观察者间一致性仅为一般,基于这些迹象预测实际梗死大小的准确性也仅为中等。